Yahoo
Shanghai - Delayed Quote CNY

Shanghai Sanyou Medical Co., Ltd (688085.SS)

12.03 -0.22 (-1.80%)
At close: 3:00:02 PM GMT+8
Chart Range Bar
Loading chart for 688085.SS
  • Previous Close 12.25
  • Open 12.13
  • Bid 12.01 x --
  • Ask 12.03 x --
  • Day's Range 11.93 - 12.35
  • 52 Week Range 11.12 - 21.68
  • Volume 2,970,618
  • Avg. Volume 3,034,442
  • Market Cap (intraday) 4.413B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 92.54
  • EPS (TTM) 0.13
  • Earnings Date --
  • Forward Dividend & Yield 0.02 (0.16%)
  • Ex-Dividend Date Jun 11, 2026
  • 1y Target Est --

Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. It is also involved in production of ultrasonic power equipment and consumables. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and shoulder and elbow system, hip and pelvis system, knee joint system, foot and ankle, and palm and wrist systems. In addition, the company offers spinal implant, trauma implant consumables, ultrasonic power system products, and vertebral body shaping consumables. Further, it provides sports medicine and surgical equipment. Shanghai Sanyou Medical Co., Ltd. was founded in 2005 and is based in Shanghai, China.

www.sanyoumed.com

539

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

688085.SS
26.45%
SSE Composite Index (000001.SS)
9.09%

1-Year Return

688085.SS
35.03%
SSE Composite Index (000001.SS)
9.26%

3-Year Return

688085.SS
25.35%
SSE Composite Index (000001.SS)
19.05%

5-Year Return

688085.SS
33.67%
SSE Composite Index (000001.SS)
3.13%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.21%

  • Return on Assets (ttm)

    1.00%

  • Return on Equity (ttm)

    1.22%

  • Revenue (ttm)

    591.46M

  • Net Income Avi to Common (ttm)

    48.55M

  • Diluted EPS (ttm)

    0.13

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    516.04M

  • Total Debt/Equity (mrq)

    3.44%

  • Levered Free Cash Flow (ttm)

    -28.92M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: